Skip to content

13F-HR filed by DAFNA Capital Management LLC

DAFNA Capital Management LLC filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-15, with 80 holding rows worth $376,924,000.

Accession
0001389933-21-000011
Filed
2021-11-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2021

A holdings report, 80 entries on the cover page, a total value of $376,924,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $376,924,000 with VALUE read as thousands by filing date, 13F file number 028-12327. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
STEREOTAXIS INC85916J409COMMON STOCK13,680,554$73,601,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM206,911$21,273,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM344,360$20,410,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM88,100$12,238,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM587,456$11,843,000thousands by filing date
IDEAYA BIOSCIENCES INC COM45166A102Stock460,061$11,727,000thousands by filing date
DEXCOM INC COM252131107Stock21,138$11,560,000thousands by filing date
MORPHIC HLDG INC61775R105COM181,467$10,278,000thousands by filing date
NURIX THERAPEUTICS INC67080M103COMMON STOCK306,320$9,177,000thousands by filing date
KARUNA THERAPEUTICS INC48576A100COM74,585$9,124,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM84,655$8,119,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM180,306$7,989,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW119,615$7,123,000thousands by filing date
ISHARES TR464287556ISHARES BIOTECH40,900$6,613,000thousands by filing date
CARDIOVASCULAR SYSTEMS INC141619106COMMON STOCK193,741$6,361,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW175,000$6,255,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock406,535$6,212,000thousands by filing date
AFFIMED N VN01045108COM964,857$5,963,000thousands by filing date
REVOLUTION MEDICINES INC COM76155X100Stock209,731$5,770,000thousands by filing date
F-STAR THERAPEUTICS INC30315R107COM693,785$5,079,000thousands by filing date
ATRICURE INC04963C209COM72,029$5,010,000thousands by filing date
OTONOMY INC68906L105COM2,379,392$4,568,000thousands by filing date
ARCUS BIOSCIENCES INC03969F109COM123,700$4,313,000thousands by filing date
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR77,675$4,086,000thousands by filing date
ACCURAY INC DEL004397105COM941,800$3,720,000thousands by filing date
RADIUS HEALTH INC750469AA6NOTE4,000,000$3,630,000thousands by filing dateprincipal
IVERIC BIO INC46583P102COM216,351$3,514,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM189,163$3,301,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM289,040$3,295,000thousands by filing date
PARDES BIOSCIENCES INC COM30318F100Stock299,950$2,985,000thousands by filing date
ADICET BIO INC007002108COM376,281$2,950,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK809,000$2,937,000thousands by filing date
MERUS N VN5749R100COM131,949$2,903,000thousands by filing date
VIKING THERAPEUTICS INC92686J106COM447,400$2,810,000thousands by filing date
VENUS CONCEPT INC92332W105COM1,113,228$2,794,000thousands by filing date
TURNING PT THERAPEUTICS90041T108COM41,952$2,787,000thousands by filing date
KADMON HLDGS INC48283N106COM314,561$2,740,000thousands by filing date
MEREO BIOPHARMA GROUP PLC589492107CMN1,126,613$2,726,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO296,383$2,481,000thousands by filing date
89BIO INC282559103COM126,652$2,481,000thousands by filing date
ALECTOR INC014442107COMMON STOCK107,412$2,451,000thousands by filing date
KINNATE BIOPHARMA INC49705R105COM106,453$2,451,000thousands by filing date
NATUS MEDICAL INC639050103COM95,653$2,399,000thousands by filing date
ITEOS THERAPEUTICS INC46565G104COM83,061$2,243,000thousands by filing date
NEURONETICS INC64131A105COM313,717$2,058,000thousands by filing date
CENTURY THERAPEUTICS INC15673T100COM80,000$2,013,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM524,286$1,914,000thousands by filing date
HOOKIPA PHARMA INC43906K100COM322,124$1,897,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock100,829$1,889,000thousands by filing date
MACROGENICS INC556099109COM90,000$1,885,000thousands by filing date
COGENT BIOSCIENCES INC19240Q201COM223,554$1,880,000thousands by filing date
PHASEBIO PHARMACEUTICALS INC717224109COM603,042$1,875,000thousands by filing date
MEI PHARMA INC55279B202COM NEW641,000$1,769,000thousands by filing date
BRAINSWAY LTD10501L106CMN200,000$1,612,000thousands by filing date
SUTRO BIOPHARMA INC869367102COM85,000$1,606,000thousands by filing date
FIELD TRIP HEALTH LTD31656R102COM340,900$1,565,000thousands by filing date
Inflarx NvN44821101COM600,000$1,554,000thousands by filing date
SYNDAX PHARMACEUTICALS INC87164F105COM80,702$1,542,000thousands by filing date
ATHIRA PHARMA INC04746L104COM160,983$1,510,000thousands by filing date
NGM BIOPHARMACEUTICALS INC62921N105COM65,485$1,376,000thousands by filing date
AERIE PHARMACEUTICALS INC00771VAB4NOTE 1.500%10/01,500,000$1,375,000thousands by filing dateprincipal
Mersana Therapeutics Inc59045L106Common Stock140,263$1,323,000thousands by filing date
ASLAN PHARMACEUTICALS LTD04522R101ADR732,500$1,304,000thousands by filing date
BOLT BIOTHERAPEUTICS INC097702104COM100,000$1,265,000thousands by filing date
NEXTCURE INC65343E108COM183,491$1,237,000thousands by filing date
COMPUGEN LTDM25722105ORD201,502$1,203,000thousands by filing date
ALPINE IMMUNE SCIENCES INC02083G100COM111,501$1,190,000thousands by filing date
HARPOON THERAPEUTICS INC41358P106COM105,163$831,000thousands by filing date
LAVA THERAPEUTICS NVN51517105SHS139,332$825,000thousands by filing date
MASIMO CORP COM574795100Stock3,000$812,000thousands by filing date
INFINITY PHARMACEUTICALS INC45665G303COM236,160$808,000thousands by filing date
LARIMAR THERAPEUTICS INC517125100COM64,487$744,000thousands by filing date
GENFIT S A372279109ADS188,549$698,000thousands by filing date
INOGEN INC45780L104COM15,000$646,000thousands by filing date
SURGALIGN HOLDINGS INC86882C105COM579,710$632,000thousands by filing date
PHARVARIS NVN69605108COMMON STOCK35,074$622,000thousands by filing date
MADRIGAL PHARMACEUTICALS INC COM558868105Stock5,600$447,000thousands by filing date
ANNEXON INC03589W102COM23,296$434,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW14,500$180,000thousands by filing date
VASCULAR BIOGENICS LTDM96883109COM55,000$113,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001389933-21-000011this filing2021-11-15acceptance time not in the bulk data set